Wire Stories
-
499CT Group Appoints Managing Director to Grow South-East Asia Focus
LONDON–(BUSINESS WIRE)–CT Group is delighted to announce the appointment of Abdul Malik to the role of Managing Director, Singapore. Malik will lead...
-
596Brambles ranked world�s third most sustainable company by Corporate Knights� Global 100
CHEP operator recognized as sustainability leader in the circular economy ATLANTA–(BUSINESS WIRE)–Brambles, a global leader in supply chain solutions operating through the...
-
609CARBONCO Signs an MOU With Saudi Arabia’s SWCC, the World’s Largest Seawater Desalination Institution, for the CCUS Project
Seeks to introduce CCUS technology to power plants and seawater desalination processes in Saudi Arabia Agreed to conduct joint research in various...
-
537Versa Networks is Industry�s First SASE Provider to Earn Compliance with �Make in India� Initiative
�Make in India� Initiative Compliance Offers Competitive Advantage in the Rapidly Growing India Market, Particularly in Federal Sales SANTA CLARA, Calif. &...
-
415Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata
Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun Pharma�s Global...
-
476Draslovka�s Breakthrough Glycine Leaching Technology Is Selected as Part of Tailings Reduction Initiative With Rio Tinto, OZ Minerals and Boliden
PRAGUE–(BUSINESS WIRE)–Draslovka Holding a.s. (�Draslovka� or �the Company�), a Czech family-owned global leader in CN-based specialty chemicals, including sustainable solutions for the...
-
474NextDecade and Itochu Corporation Execute 1.0 MTPA LNG Sale and Purchase Agreement
HOUSTON–(BUSINESS WIRE)–NextDecade Corporation (NextDecade) (NASDAQ: NEXT) announced today the execution of a 15-year sale and purchase agreement (SPA) with Itochu Corporation (Itochu)...
-
513BRUKINSA� (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA
MHRA marketing authorizations follow recent European Commission marketing authorizations BRUKINSA is the only treatment authorized for MZL in Great Britain CAMBRIDGE, Mass....
-
418E2open�s Ocean Shipping Index Reveals Notably Improved Cross-Ocean Transit Time for Global Freight Deliveries
Latest report highlights how lessened demand for goods from Asia has continued to reduce port congestion, resulting in an average eight-day decrease...
-
853Repare Therapeutics Receives $1.5 Million (�200 million) Payment from Ono Pharmaceuticals
CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (�Repare� or the �Company�) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that...
